A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer
Clinical trial NCT06630325 · TERMINATED
Trial details
- NCT number
- NCT06630325
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-24
- Primary completion
- 2026-03-11
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.